First report of CrpP prevalence in a South American country

• Autores: Ruiz, Joaquim, Ocampo, Karen, Salvador Luján, Gina, Reyes, Yelinda V., Gómez, Andrea C., Valera Krumdieck, Carmen, Baca Cumpa, Ariana D., Soza, Gabriela, Pinto, Joseph A., Ramos Chirinos, María, Lagos, José, Riveros, Maribel, Pons, Maria J.
• Formato: artículo
• Fecha de Publicación: 2023
• Institución: Seguro Social de Salud
• Repositorio: ESSALUD-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.essalud.gob.pe:20.500.12959/3474
• Enlace del recurso: https://hdl.handle.net/20.500.12959/3474; https://doi.org/10.1016/j.nmni.2023.101082
• Nivel de acceso: acceso abierto
• Materia: CrpP; Phosphorylase; PMQR; Quinolone-resistance; TMQR; Fosforilasa; Resistencia a quinolonas; https://purl.org/pe-repo/ocde/ford#3.02.17

The presence of crpP was established in 201 Pseudomonas aeruginosa isolates from 9 Peruvian hospitals. The 76.6% (154/201) of the isolates presented the crpP gene. Overall, 123/201 (61.2%) isolates were non-susceptible to ciprofloxacin. The prevalence of crpP-possessing P. aeruginosa in Peru is higher than in other geographical areas.